Return to search

Investigation of the use of recombinant BCG, expressing the major capsid protein (LI) of human papillomavirus type 16, as a candidate vaccine for cervical cancer

Includes bibliographical references (leaves 214-236).

Identiferoai:union.ndltd.org:netd.ac.za/oai:union.ndltd.org:uct/oai:localhost:11427/2730
Date January 2005
CreatorsMacLean, James Malcolm
ContributorsWilliamson, Anna-Lise
PublisherUniversity of Cape Town, Faculty of Health Sciences, Division of Virology
Source SetsSouth African National ETD Portal
LanguageEnglish
Detected LanguageEnglish
TypeDoctoral Thesis, Doctoral, PhD
Formatapplication/pdf

Page generated in 0.0014 seconds